EBSCO Logo
Connecting you to content on EBSCOhost
Title

Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application.

Authors

Susidarti, Ratna; Utomo, Rohmad; Qodria, Lailatul; Ramadani, Ratna; Ohta, Youichiro; Hattori, Yoshihide; Kirihata, Mitsunori; Meiyanto, Edy

Abstract

Development of specific and selective boron carriers is indispensable for boron neutron capture therapy (BNCT) application. Pentagamaboronon-0 (PGB-0) is a promising candidate as boron carrier compound due to the low but selective cytotoxicity in breast cancer cells. Formerly we reported synthesis of PGB-0 which was ineffective due to its low aqueous solubility. In the present study, we, therefore, introduced the new PGB-0 preparation complexed with sugars to increase its solubility in water. By synthesizing at room temperature and using flash chromatography for the purification, we produced PGB-0 with a yield of 40%. PGB-0 fructose complex (PGB-0-F) and PGB-0 sorbitol complex (PGB-0-Sor) were obtained with smaller particle size compared to PGB-0 suspension in water. Based on the MTT assay, the cytotoxicity of PGB-0-F and PGB-0-Sor were higher than PGB-0 even though still categorized as low cytotoxic agents. In conclusion, we provided PGB-0 with a new method and improved its solubility in water. Further investigations are still needed to develop more efficient PGB-0 as boron carrier for BNCT in various cancers.

Subjects

BORON-neutron capture therapy; SORBITOL; FRUCTOSE; BORON

Publication

Research in Pharmaceutical Sciences, 2019, Vol 14, Issue 4, p286

ISSN

1735-5362

Publication type

Academic Journal

DOI

10.4103/1735-5362.263552

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved